p53-dependent ceramide response to genotoxic stress.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Investigation

• Publication date

  1998-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI1180PMID 9664074PMCID PMC508891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingolipid-Mediated Signal Transduction

  2013cited by this paper
• Cell cycle control and cancer.

  2000cited by this paper
• Phospholipase A2 Is Necessary for Tumor Necrosis Factor α-induced Ceramide Generation in L929 Cells*

  1997cited by this paper
• Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic Pathway

  1997influential reference
• Fas-induced apoptosis of T cells occurs independently of ceramide generation.

  1997cited by this paper
• Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells

  1997influential reference
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper
• Bcl-2 interrupts the ceramide-mediated pathway of cell death.

  1996influential reference
• Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis.

  1996cited by this paper
• prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2.

  1996cited by this paper
• Functions of Ceramide in Coordinating Cellular Responses to Stress

  1996cited by this paper
• Daunorubicin‐induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis.

  1996cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.

  1995cited by this paper
• Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein

  1995cited by this paper
• Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation.

  1995cited by this paper
• Ceramide: an endogenous regulator of apoptosis and growth suppression.

  1995cited by this paper
• Role of Ceramide in Cellular Senescence (*)

  1995cited by this paper
• Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity.

  1995cited by this paper
• Increased activity of p53 in senescing fibroblasts.

  1995cited by this paper
• Role for Ceramide in Cell Cycle Arrest (*)

  1995influential reference
• mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations.

  1995cited by this paper
• Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

  1995cited by this paper
• Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

  1995influential reference
• Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

  1995cited by this paper
• Inhibition of ceramide-induced apoptosis by Bcl-2.

  1995cited by this paper
• Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals.

  1995cited by this paper
• Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

  1995cited by this paper
• Radiation-induced cell cycle arrest compromised by p21 deficiency

  1995cited by this paper
• Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells.

  1994cited by this paper
• DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.

  1994cited by this paper
• p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes

  1994cited by this paper
• Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

  1994cited by this paper
• p53, guardian of Rb

  1994cited by this paper
• Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein.

  1994cited by this paper
• Absence of WAF1 mutations in a variety of human malignancies.

  1994cited by this paper
• Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase

  1994cited by this paper
• Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis

  1994cited by this paper
• The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest

  1994influential reference
• Cell cycle control and cancer.

  1994cited by this paper
• The p53-dependent gamma-ray response of GADD45.

  1994cited by this paper
• p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

  1994cited by this paper
• Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.

  1994cited by this paper
• CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.

  1994cited by this paper
• Tumour biology. p53, guardian of Rb.

  1994cited by this paper
• The sphingomyelin cycle and the second messenger function of ceramide.

  1994cited by this paper
• WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

  1994cited by this paper
• p53 and Rb: their cellular roles.

  1994cited by this paper
• 1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells.

  1994cited by this paper
• DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis.

  1994cited by this paper
• The p53-dependent γ-Ray Response of GADD45

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.

  1993cited by this paper
• Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

  1993cited by this paper
• Programmed cell death induced by ceramide.

  1993influential reference
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• What the papers say: The p53‐mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53?

  1993cited by this paper
• Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide.

  1993cited by this paper
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

  1993cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs.

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

  1991influential reference
• Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation.

  1990cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D.

  1988cited by this paper
• Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells.

  1986cited by this paper
• Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

  1970cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells

  2026cites this paper
• A career in bioactive lipids

  2025cites this paper
• Modulation of Ceramide-Induced Apoptosis in Enteric Neurons by Aryl Hydrocarbon Receptor Signaling: Unveiling a New Pathway beyond ER Stress

  2024cites this paper
• Baicalin ameliorates Mycoplasma gallisepticum-induced inflammatory injury via inhibiting STIM1-regulated ceramide accumulation in DF-1 cells

  2023cites this paper
• Targeting sphingosine kinase 1 in p53KO thymic lymphoma

  2023cites this paper
• Lipids as Regulators of Cellular Senescence

  2022cites this paper
• Implications of Sphingolipids on Aging and Age-Related Diseases

  2022cites this paper
• Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations under hypoxic conditions.

  2022cites this paper
• Lipidomics profiling of biological aging in American Indians: the Strong Heart Family Study

  2022cites this paper
• Metabolic response to radiation therapy in cancer

  2021cites this paper
• The unfolding role of ceramide in coordinating retinoid-based cancer therapy.

  2021cites this paper
• A new caffeic acid ester and a new ceramide from the roots of Eriosema glomeratum

  2021cites this paper
• Modulation of DNA Damage Response by Sphingolipid Signaling: An Interplay that Shapes Cell Fate

  2020cites this paper
• Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate

  2020cites this paper
• Crosstalk between Noxa, Bcl-2, and ceramide in mediating p53-dependent apoptosis in Molt-4 human T-cell leukemia

  2020cites this paper
• Sphingolipids and the link between alcohol and cancer.

  2020cites this paper
• Recent advances in the formulation of sphingolipid anticancer therapeutics

  2020cites this paper
• Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.

  2020cites this paper
• Ceramide synthases in cancer therapy and chemoresistance.

  2019cites this paper
• Magnesium Deficiency, Sphingolipids, and Telomerase: Relevance to Atherogenesis, Cardiovascular Diseases, and Aging

  2019cites this paper
• Ceramide synthases in cancer therapy and chemoresistance.

  2019cites this paper
• The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders

  2019cites this paper
• Ceramide Suppresses Influenza A Virus Replication In Vitro

  2019cites this paper
• Ceramide–Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations

  2019cites this paper
• Identificación de dianas terapéuticas en fibrosis hepática y cáncer

  2018cites this paper
• Manifestations and mechanisms of myocardial lipotoxicity in obesity

  2018cites this paper
• TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition

  2018cites this paper
• Cancer chemotherapy failure: a synthetic view

  2018cites this paper
• The Cross-Talk Between Sphingolipids and Insulin-Like Growth Factor Signaling: Significance for Aging and Neurodegeneration

  2018cites this paper
• Role of sphingolipids in senescence: implication in aging and age‐related diseases

  2018cites this paper
• Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy.

  2018cites this paper
• Ceramide Signaling and p53 Pathways: CHAPTER SEVEN

  2018cites this paper
• Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2

  2017cites this paper
• In vitro and in vivo anti-leukemic effects of cladoloside C2 are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH2-terminal kinase/caspase-8

  2017cites this paper
• Genomic alterations during p53-dependent apoptosis induced by γ-irradiation of Molt-4 leukemia cells

  2017cites this paper
• Lipid-induced cardiovascular diseases

  2017cites this paper
• Assessment and Control of a Cavitation-Enabled Therapy for Minimally Invasive Myocardial Reduction

  2017cites this paper
• Role of p53 in muscle wasting

  2016cites this paper
• Ceramide regulation by E4orf4 gene during adenoviral infection

  2016cites this paper
• LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity.

  2016cites this paper
• Subcellular mechanisms involved in apoptosis induced by aminoglycoside antibiotics: Insights on p53, proteasome and endoplasmic reticulum.

  2016cites this paper
• Augmentation of Curcumin Induced Cell Death by Cell Permeable C2 Ceramide in Human T-lymphoma Jurkat Cell Line

  2016cites this paper
• Unraveling the role of the Target of Rapamycin signaling in sphingolipid metabolism.

  2016cites this paper
• Tumor suppressive functions of ceramide: evidence and mechanisms

  2015cites this paper
• Role of Sphingolipids in Hematological Malignancies: Lymphoproliferative Disorders

  2015cites this paper
• P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest

  2015cites this paper
• Description of the Sphingolipid Content and Subspecies in the Diabetic Cornea

  2015cites this paper
• Sphingolipids in the DNA damage response.

  2015cites this paper
• Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.

  2014cites this paper
• Preclinical ef fi cacy of the synthetic retinoid ST 1926 for treating adult T-cell leukemia / lymphoma

  2014cites this paper
• Regulation of ceramide by the novel synthetic retinoid ST1926-induced cell death in HTLV-1 transformed and malignant T Cells -

  2014cites this paper
• Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

  2014cites this paper
• Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.

  2014cites this paper
• Sphingolipid Metabolism and Signaling as a Target for Cancer Treatment

  2013cites this paper
• Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6*

  2013cites this paper
• p53 and Ceramide as Collaborators in the Stress Response

  2013cites this paper
• Functional-Network-Based Gene Set Analysis Using Gene-Ontology

  2013cites this paper
• Methylated actinomycin D, a novel actinomycin D analog induces apoptosis in HepG2 cells through Fas‐ and mitochondria‐mediated pathways

  2013cites this paper
• Role of ceramide in the physiology and pathophysiology of nervous systems

  2013cites this paper
• Ceramides, Cerebrosides, and Related Long Chains Containing Derivatives from the Medicinal Plants of Africa

  2013cites this paper
• Protein Kinase Cδ in Apoptosis: A Brief Overview

  2012cites this paper
• Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro

  2012cites this paper
• Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death.

  2012cites this paper
• Curcumin Induces Human Colon Cancer Cell death via p62/SQSTM1 Degradation, Phospho-ERK Up-regulation and Ceramide Generation

  2012cites this paper
• Effects of long term exposure to the mycotoxin fumonisin B1 in p53 heterozygous and p53 homozygous transgenic mice.

  2012cites this paper
• Glutathione regulates caspase-dependent ceramide production and curcumin-induced apoptosis in human leukemic cells.

  2012cites this paper
• Age-Dependent Changes in the Sphingolipid Composition of Mouse CD4+ T Cell Membranes and Immune Synapses Implicate Glucosylceramides in Age-Related T Cell Dysfunction

  2012cites this paper
• Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.

  2012cites this paper
• Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation

  2011cites this paper
• Resuscitating wild-type p53 expression by disrupting ceramide glycosylation: a novel approach to target mutant p53 tumors.

  2011cites this paper
• The role of the Golgi apparatus in oxidative stress: is this organelle less significant than mitochondria?

  2011cites this paper
• Defining a role for sphingosine kinase 1 in p53-dependent tumors

  2011cites this paper
• Glutathione selectively inhibits Doxorubicin induced phosphorylation of p53Ser¹⁵, caspase dependent ceramide production and apoptosis in human leukemic cells.

  2011cites this paper
• Effect of diethylcarbamazine, butylated hydroxy anisole and methyl substituted chalcone on filarial parasite Setaria cervi: proteomic and biochemical approaches.

  2011influential citation
• Ceramide Synthase-dependent Ceramide Generation and Programmed Cell Death

  2011cites this paper
• Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.

  2011cites this paper
• Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.

  2011cites this paper
• p53 and regulation of bioactive sphingolipids.

  2011cites this paper
• Augmentation of chemotherapy-triggered glioma cell apoptosis by blockade of arachidonic acid metabolism--the potential role of ceramide accumulation.

  2011cites this paper
• The Role of Ceramide in Cell Regulation

  2010cites this paper
• Combination of DEC plus aspirin induced mitochondrial mediated apoptosis in filarial parasite Setaria cervi.

  2010cites this paper
• Involvement of DNA-PK and ATM in radiation- and heat-induced DNA damage recognition and apoptotic cell death.

  2010cites this paper
• Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment.

  2010cites this paper
• Short-term magnesium deficiency upregulates sphingomyelin synthase and p53 in cardiovascular tissues and cells: relevance to the de novo synthesis of ceramide.

  2010influential citation
• Diversity and complexity of ceramide generation after exposure of jurkat leukemia cells to irradiation.

  2009cites this paper
• Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells.

  2009cites this paper
• Identification of ionizing radiation-responsive microRNAs in the IM9 human B lymphoblastic cell line.

  2009cites this paper
• Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan

  2009cites this paper
• Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells

  2009cites this paper
• The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells.

  2009cites this paper
• Shared pathways: Death receptors and cytotoxic drugs in cancer therapy

  2009cites this paper
• De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation.

  2008cites this paper
• Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.

  2007cites this paper
• PPP1CA contributes to the senescence program induced by oncogenic Ras.

  2007cites this paper
• Imparting cell adhesion to poly(vinyl alcohol) hydrogel by coating with hydroxyapatite thin film

  2007cites this paper
• Phospholipase D protects ECV304 cells against TNFalpha-induced apoptosis.

  2006cites this paper
• Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia

  2006cites this paper
• A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.

  2006cites this paper
• Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

  2006cites this paper
• Sphingolipids in cancer: Regulation of pathogenesis and therapy

  2006cites this paper